A rare genetic mutation that causes a deficiency in an immune regulator called ISG15 is known to make people more vulnerable to some bacterial infections and cause persistent inflammation — but it can unlock some unexpected antiviral "superpowers" as well.

As detailed in a new study published in the journal Science Translational Medicine, a team of scientists led by Columbia University professor of pediatric immunology, Dusan Bogunovic, has developed a new antiviral therapy that temporarily gives patients the same powerful antiviral properties by administering an experimental drug via a nasal drip.

The research kicked off with a happy accident.

"Our findings reinforce the power of research driven by curiosity without preconceived notions," said Bogunovic, in a statement about the resear

See Full Page